 Intra-Cellular Therapies, Inc. NASDAQ:ITCI Q2 2022 Earnings Conference Call August 9, 2022 8:30 AM ET Company Participants Juan Sanchez - Vice President, Corporate Communications and Investor Relations Sharon Mates - Chairman and Chief Executive Officer Mark Neumann - Executive Vice President and Chief Commercial Officer Suresh Durgam - Executive Vice President Chief Medical Officer Larry Hineline - Senior Vice President and Chief Financial Officer Conference Call Participants Andrew Tsai - Jefferies Jessica Fye - JPMorgan Mike DiFiore - Evercore Brian Abrahams - RBC Capital Markets Charles Duncan - Cantor Fitzgerald Marc Goodman - SVB Karin Jenkins - Goldman Sachs Jason Gerberry - Bank of America Ash Verma - UBS Sumant Kulkarni - Canaccord Operator Good morning, ladies and gentlemen, and welcome to the Intra-Cellular Therapies Second Quarter Earnings Call. At this time, all participants on a listen-only mode. 